FDA Inspection
Park Avenue CompoundingPark Avenue Compounding – FDA Inspection, Feb 8, 2024
Record Details
This FDA Inspection record concerns Park Avenue Compounding, with an inspection on February 8, 2024, covering drugs.
- Company
- Park Avenue Compounding
- Inspection Date
- February 8, 2024
- Product Type
- Drugs
View Company Profile
ID · 467262c2-d651-4d04-9fb8-2e55cdacb3c7
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1231487
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Park Avenue Compounding
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 23, 2025 | Not classified | Kansas City District Office | Drug Quality Assurance |
| August 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 16, 2017 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 5, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Park Avenue Compounding
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.